Evaluation and Treatment of Autoimmune Neurologic Disorders in the Pediatric Intensive Care Unit

Autoimmunity is being increasingly recognized as a cause of neurologic presentations both inside and outside the intensive care unit (ICU) setting. Pediatric autoimmune neurologic diseases likely to be seen in the ICU include autoimmune encephalitidies such as N-Methyl-D-aspartate (NMDA) receptor en...

Full description

Saved in:
Bibliographic Details
Published in:Seminars in pediatric neurology Vol. 21; no. 4; pp. 284 - 290
Main Authors: Benson, Leslie A., Olson, Heather, Gorman, Mark P.
Format: Journal Article
Language:English
Published: United States Elsevier Inc 01.12.2014
Subjects:
ISSN:1071-9091, 1558-0776, 1558-0776
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Autoimmunity is being increasingly recognized as a cause of neurologic presentations both inside and outside the intensive care unit (ICU) setting. Pediatric autoimmune neurologic diseases likely to be seen in the ICU include autoimmune encephalitidies such as N-Methyl-D-aspartate (NMDA) receptor encephalitis, central nervous system vasculitis, demyelinating disorders, and neurologic involvement of systemic autoimmune disorders. In addition, there are conditions of suspected autoimmune etiology such as febrile infection–related epilepsy syndrome (FIRES) and rapid-onset obesity, hypoventilation, hypothalamic dysfunction, and autonomic dysregulation (ROHHAD) syndrome that are rare, but when they do present, it is often to the ICU. Refractory seizures, altered mental status, and disordered breathing are the most common indications for intensive care for these patients.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:1071-9091
1558-0776
1558-0776
DOI:10.1016/j.spen.2014.12.008